CA2355920A1 - Methods and kits for screening nucleic acid duplex stability - Google Patents

Methods and kits for screening nucleic acid duplex stability Download PDF

Info

Publication number: CA2355920A1
Authority: CA; Canada
Prior art keywords: nucleic acid; duplex; strand; target; initial
Prior art date: 1998-12-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002355920A

Other languages

English (en)

French (fr)

Inventor

Kenneth J. Breslauer

Craig A. Gelfand

G. Eric Plum

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Rutgers State University of New Jersey

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-23

Filing date

1999-12-23

Publication date

2000-06-29

1999-12-23 Application filed by Individual filed Critical Individual

2000-06-29 Publication of CA2355920A1 publication Critical patent/CA2355920A1/en

Status Abandoned legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 160
108020004707 nucleic acids Proteins 0.000 title claims abstract description 150
102000039446 nucleic acids Human genes 0.000 title claims abstract description 150
238000000034 method Methods 0.000 title claims abstract description 101
238000012216 screening Methods 0.000 title claims description 24
230000002860 competitive effect Effects 0.000 claims abstract description 8
102000054765 polymorphisms of proteins Human genes 0.000 claims abstract description 5
239000000370 acceptor Substances 0.000 claims description 97
230000015572 biosynthetic process Effects 0.000 claims description 47
239000002773 nucleotide Substances 0.000 claims description 21
125000003729 nucleotide group Chemical group 0.000 claims description 21
238000001816 cooling Methods 0.000 claims description 16
238000010438 heat treatment Methods 0.000 claims description 13
230000008859 change Effects 0.000 claims description 12
230000000295 complement effect Effects 0.000 claims description 12
108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
238000001514 detection method Methods 0.000 claims description 9
238000012544 monitoring process Methods 0.000 claims description 9
208000035657 Abasia Diseases 0.000 claims description 7
230000005284 excitation Effects 0.000 claims description 7
239000007850 fluorescent dye Substances 0.000 claims description 7
238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims description 4
238000000954 titration curve Methods 0.000 claims description 4
239000007787 solid Substances 0.000 claims description 3
230000007423 decrease Effects 0.000 claims 1
125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 claims 1
102000040430 polynucleotide Human genes 0.000 abstract 1
108091033319 polynucleotide Proteins 0.000 abstract 1
239000002157 polynucleotide Substances 0.000 abstract 1
238000003556 assay Methods 0.000 description 43
108020004414 DNA Proteins 0.000 description 41
238000004448 titration Methods 0.000 description 38
239000000243 solution Substances 0.000 description 37
230000006870 function Effects 0.000 description 36
239000000975 dye Substances 0.000 description 28
238000002474 experimental method Methods 0.000 description 27
108091034117 Oligonucleotide Proteins 0.000 description 23
238000012360 testing method Methods 0.000 description 21
239000000523 sample Substances 0.000 description 15
238000007792 addition Methods 0.000 description 14
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 13
238000005259 measurement Methods 0.000 description 13
239000000872 buffer Substances 0.000 description 12
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
230000007547 defect Effects 0.000 description 8
230000000694 effects Effects 0.000 description 8
230000003902 lesion Effects 0.000 description 8
238000002835 absorbance Methods 0.000 description 7
238000012546 transfer Methods 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
AWZJFZMWSUBJAJ-UHFFFAOYSA-N OG-514 dye Chemical compound OC(=O)CSC1=C(F)C(F)=C(C(O)=O)C(C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)=C1F AWZJFZMWSUBJAJ-UHFFFAOYSA-N 0.000 description 6
230000004048 modification Effects 0.000 description 6
238000012986 modification Methods 0.000 description 6
239000008186 active pharmaceutical agent Substances 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
230000014509 gene expression Effects 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
230000008018 melting Effects 0.000 description 5
238000002844 melting Methods 0.000 description 5
108090000623 proteins and genes Proteins 0.000 description 5
238000006467 substitution reaction Methods 0.000 description 5
238000004458 analytical method Methods 0.000 description 4
230000008901 benefit Effects 0.000 description 4
238000004364 calculation method Methods 0.000 description 4
238000000295 emission spectrum Methods 0.000 description 4
238000012869 ethanol precipitation Methods 0.000 description 4
239000000463 material Substances 0.000 description 4
XLXOKMFKGASILN-UHFFFAOYSA-N rhodamine red-X Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(=O)(=O)NCCCCCC(O)=O)C=C1S([O-])(=O)=O XLXOKMFKGASILN-UHFFFAOYSA-N 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
230000004075 alteration Effects 0.000 description 3
230000003321 amplification Effects 0.000 description 3
230000004888 barrier function Effects 0.000 description 3
230000000711 cancerogenic effect Effects 0.000 description 3
231100000357 carcinogen Toxicity 0.000 description 3
239000003183 carcinogenic agent Substances 0.000 description 3
238000012937 correction Methods 0.000 description 3
238000007405 data analysis Methods 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
239000011521 glass Substances 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
150000008300 phosphoramidites Chemical class 0.000 description 3
238000011160 research Methods 0.000 description 3
230000003595 spectral effect Effects 0.000 description 3
239000011550 stock solution Substances 0.000 description 3
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
229910017974 NH40H Inorganic materials 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
238000000137 annealing Methods 0.000 description 2
230000000692 anti-sense effect Effects 0.000 description 2
230000008033 biological extinction Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000000113 differential scanning calorimetry Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
238000000695 excitation spectrum Methods 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
238000002372 labelling Methods 0.000 description 2
239000000155 melt Substances 0.000 description 2
239000000203 mixture Substances 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
230000003094 perturbing effect Effects 0.000 description 2
230000008569 process Effects 0.000 description 2
239000000047 product Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
150000003212 purines Chemical class 0.000 description 2
150000003230 pyrimidines Chemical class 0.000 description 2
230000009467 reduction Effects 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
238000004007 reversed phase HPLC Methods 0.000 description 2
239000012488 sample solution Substances 0.000 description 2
229910001415 sodium ion Inorganic materials 0.000 description 2
238000004611 spectroscopical analysis Methods 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000011282 treatment Methods 0.000 description 2
125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
201000003695 Alexia Diseases 0.000 description 1
241000752021 Alexia Species 0.000 description 1
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
230000008836 DNA modification Effects 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
239000012630 HPLC buffer Substances 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
241000288724 Talpa europaea Species 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
238000000862 absorption spectrum Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
235000012538 ammonium bicarbonate Nutrition 0.000 description 1
239000001099 ammonium carbonate Substances 0.000 description 1
239000002259 anti human immunodeficiency virus agent Substances 0.000 description 1
239000000427 antigen Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000010420 art technique Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
239000011324 bead Substances 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000002983 circular dichroism Methods 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
238000003271 compound fluorescence assay Methods 0.000 description 1
238000013329 compounding Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000009795 derivation Methods 0.000 description 1
238000011033 desalting Methods 0.000 description 1
238000006642 detritylation reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
206010013932 dyslexia Diseases 0.000 description 1
238000010828 elution Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
229940125532 enzyme inhibitor Drugs 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
238000011067 equilibration Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012467 final product Substances 0.000 description 1
238000007667 floating Methods 0.000 description 1
238000001917 fluorescence detection Methods 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
238000013537 high throughput screening Methods 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000011068 loading method Methods 0.000 description 1
239000008176 lyophilized powder Substances 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
231100000219 mutagenic Toxicity 0.000 description 1
230000003505 mutagenic effect Effects 0.000 description 1
230000035772 mutation Effects 0.000 description 1
238000002966 oligonucleotide array Methods 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
239000008188 pellet Substances 0.000 description 1
230000002974 pharmacogenomic effect Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
150000004713 phosphodiesters Chemical group 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
238000009877 rendering Methods 0.000 description 1
238000012827 research and development Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
239000002195 soluble material Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000012306 spectroscopic technique Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
BGRJTUBHPOOWDU-UHFFFAOYSA-N sulpiride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-UHFFFAOYSA-N 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
238000012932 thermodynamic analysis Methods 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical compound C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA002355920A 1998-12-23 1999-12-23 Methods and kits for screening nucleic acid duplex stability Abandoned CA2355920A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US11373198P	1998-12-23	1998-12-23
US60/113,731		1998-12-23
US11990999P	1999-02-12	1999-02-12
US60/119,909		1999-02-12
PCT/US1999/030751 WO2000037686A1 (en)	1998-12-23	1999-12-23	Methods and kits for screening nucleic acid duplex stability

Publications (1)

Publication Number	Publication Date
CA2355920A1 true CA2355920A1 (en)	2000-06-29

Family

ID=26811403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002355920A Abandoned CA2355920A1 (en)	1998-12-23	1999-12-23	Methods and kits for screening nucleic acid duplex stability

Country Status (4)

Country	Link
EP (1)	EP1155152A4 (de)
AU (1)	AU773480B2 (de)
CA (1)	CA2355920A1 (de)
WO (1)	WO2000037686A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0129662D0 (en)	2001-12-11	2002-01-30	Whatman Internat Ltd	Stabilisation of double-stranded nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5925517A (en) *	1993-11-12	1999-07-20	The Public Health Research Institute Of The City Of New York, Inc.	Detectably labeled dual conformation oligonucleotide probes, assays and kits
SE9502608D0 (sv) *	1995-07-14	1995-07-14	Pharmacia Biosensor Ab	Method for nucleic acid senquencing
DE19782089T1 (de) *	1996-10-29	1999-12-23	Univ Nebraska At Lincoln Linco	Verfahren zum Nachweisen von Punktmutationen in DNA unter Verwendung von Fluoreszenzenergieübergang

1999
- 1999-12-23 AU AU23821/00A patent/AU773480B2/en not_active Ceased
- 1999-12-23 CA CA002355920A patent/CA2355920A1/en not_active Abandoned
- 1999-12-23 WO PCT/US1999/030751 patent/WO2000037686A1/en not_active Ceased
- 1999-12-23 EP EP99967559A patent/EP1155152A4/de not_active Withdrawn

Also Published As

Publication number	Publication date
EP1155152A4 (de)	2003-05-02
AU773480B2 (en)	2004-05-27
EP1155152A1 (de)	2001-11-21
AU2382100A (en)	2000-07-12
WO2000037686A1 (en)	2000-06-29

Legal Events

Date	Code	Title	Description
2004-12-08	EEER	Examination request
2006-12-27	FZDE	Discontinued

Publication	Publication Date	Title
CA2009454C (en)	2000-04-04	Detection of nucleic acid sequences by fluorescence polarization
EP0745690B1 (de)	2008-10-22	Markierte zwei-konformations oligonukleotid Sonden, Verfahren und Testsätze
US6177249B1 (en)	2001-01-23	Method for nucleic acid analysis using fluorescence resonance energy transfer
JP3795557B2 (ja)	2006-07-12	発光性標識で標識されたオリゴヌクレオチドの分解検出方法
Mergny et al.	2003	Analysis of thermal melting curves
US7399591B2 (en)	2008-07-15	Dual resonance energy transfer nucleic acid probes
EP0728218B1 (de)	2008-01-02	Hybridisierungsprobe zur nukleinsäuredetektion, universelle stammstrukturen, methoden und reagentiensätze
JP3657556B2 (ja)	2005-06-08	温度および電子ゲインについての色補正
JP2802125B2 (ja)	1998-09-24	核酸の検出方法
JP2000509608A (ja)	2000-08-02	Ｐｃｒ中のハイブリダイゼーションのモニタリング
WO2001046467A2 (en)	2001-06-28	Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators
JP2003512808A (ja)	2003-04-08	Ｐｃｒを使用する標的となる核酸を検出する方法
US6815163B1 (en)	2004-11-09	Methods and kits for screening nucleic acid duplex stability
Maelicke et al.	1973	Spectroscopic properties of oligonucleotides excised from the anticodon region of phenylalanine tRNA from yeast
JPWO1996025518A1 (ja)	1998-03-31	核酸分析用プローブおよび検出方法
AU773480B2 (en)	2004-05-27	Methods and kits for screening nucleic acid duplex stability
US7468250B2 (en)	2008-12-23	Methods and kits for screening nucleic acid duplex stability
WO2001023612A2 (en)	2001-04-05	Determining mutations by selective reaction of the 2'-ribose position in hybridized oligonucleotides
Vo-Dinh	2003	Novel fluorescent molecular beacon DNA probes for biomolecular recognition
JPH11290098A (ja)	1999-10-26	核酸染色剤、それを用いた二本鎖核酸の検出方法及び標的核酸の検出試薬
WO2003068986A1 (en)	2003-08-21	Nucleotide detection by fluorescence resonance energy transfer and methods thereof
Spears et al.	2000	Simultaneous SDA and Fluorescence Polarization Detection
JPH06153999A (ja)	1994-06-03	電荷移動型色素を用いた標的核酸の検出方法及びそれに用いるプローブ